President Joe Biden is planning to focus on semiconductors, artificial intelligence and next-generation networks in U.S.-Asia strategies, indicating future policies toward China. The Biden administration wants to rally allies to work together on a comprehensive strategy against so-called “techno-autocracies.”
More financial relief may finally be within reach for organizations suffering from the economic impact of the COVID-19 pandemic. The Consolidated Appropriations Act (CAA) of 2021, signed into law December 27, 2020, created a third round of funding for the Paycheck Protection Program (PPP). With $284 billion made available, the newly secured funds come with relaxed guidelines that make it easier for smaller businesses and previously excluded individuals to obtain a PPP loan. In addition, organizations that received funding in the first or second round of the PPP may now be eligible to secure a follow-up loan.
As we previously wrote in our OFAC 2020 Year in Review, the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) saw a drop in enforcement activity in 2020, likely due to the massive year it had in 2019 and delays due to the coronavirus pandemic.
On February 18, 2021 – CGCC member Morvillo Abramowitz Grand Iason & Anello PC announced that Karen King will be joining the firm this month as a partner. Karen, who specializes in complex commercial litigation and regulatory matters, joins the firm from Paul, Weiss, Rifkind, Wharton & Garrison LLP.
In too many ways to count, 2020 was an extraordinary year. As we move into 2021 with optimism for an end to the pandemic and better days ahead, we understand that the activity last year of the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) may not be the first thing on your mind.
The COVID-19 vaccine breakthroughs in late 2020 brought hope that the pandemic’s end could be in sight, but a return to normalcy will require widespread inoculation, raising an urgent question: Should employers mandate COVID-19 vaccinations for their workers?
As the United States races to deliver safe and effective coronavirus (COVID-19) vaccines under the Biden administration, employers, healthcare providers, and many others are assessing what it means for their industries and organizations.
On Wednesday, February 10th, China General Chamber of Commerce – USA (“CGCC”) and CGCC Foundation, the largest independent, non-governmental, non-profit organization representing Chinese investments in the United States, hosted its 2021 Lunar New Year of the Ox Gala.
On January 29, 2021, China General Chamber of Commerce – USA (“CGCC”) held an online discussion for Chinese financial institutions operating in the U.S. Hong Zhang, Chairman of CGCC’s Financial Committee, Chief Representative of China Investment Corp New York Representative Office, welcomed the attendants and hosted the meeting. Xiaomin Chen, General Counsel of CGCC, Managing Partner of DeHeng Chen, LLC; and Jiang Liu, member of the CGCC Legal Counsel Committee, Partner at Morrison & Foerster, shared their insights and answered questions from CGCC members from the financial industry.
As the United States races to deliver safe and effective coronavirus (COVID-19) vaccines under the Biden administration, employers, healthcare providers, and many others are assessing what it means for their industries and organizations. It is difficult to capture the fast-moving developments around the vaccines and the issues and opportunities they raise in real time, but here we outline a selection of key legal considerations and updates as the rollout continues to take shape. They include the status of the US Food and Drug Administration’s (FDA’s) vaccine products, distribution, key legal issues at the state level, employer mandates and employee incentives, and important liability concerns.
